Stay updated on Teclistamab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab in Multiple Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 in the site footer. No changes to study data or page navigation.SummaryDifference0.0%

- Check19 days agoChange DetectedAdded a new version entry for Study Status on 2026-03-12 (version 70); the earlier entry from 2026-02-13 was deleted.SummaryDifference0.2%

- Check27 days agoChange DetectedRecord History now shows the latest revision as v3.4.3 and removes the previous v3.4.2.SummaryDifference0.0%

- Check48 days agoChange DetectedDifference0.2%

- Check55 days agoChange DetectedA new revision entry (v3.4.1) was added to the history, and notices about government funding lapse and operating status (v3.4.0) were removed.SummaryDifference0.4%

- Check63 days agoChange DetectedA new version entry dated 2026-01-27 was added with updates to Contacts/Locations and Study Status, bringing the latest version to 68. The 2025-12-05 entry was removed, and a site-wide funding notice banner was added.SummaryDifference0.6%

Stay in the know with updates to Teclistamab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab in Multiple Myeloma Clinical Trial page.